Moreover, PRMT5 cooperates with MYC to sustain splicing fidelity, which is key to ensure tumor maintenance of MYC-driven lymphomas11, and promotes the upregulation of BCL-6 repressive activity in DLBCL12. Here, MYC is linked to neoplasm.